PFIZER INC Long-Term Concentrated

Location: New York, NY

CIK: 0000078003 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 13, 2026

Total Value: $170M (100.0% shares, 0.0% debt)

Holdings (17)

Exited Positions (1)

QTTB Q32 BIO INC 0.4%

Value $737K Shares 101,618 Est. Cost $31.58 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
QTTB	Q32 BIO INC	101,618	$737K	0.4%	$31.58	—	—	746964105

Decreased Positions (3)

ORIC ORIC PHARMACEUTICALS INC 2.1%

Value $3.554M (-93.8%) Shares 372,904 (-92.2%) Est. Cost $9.18 Unrealized —

ZURA ZURA BIO LTD 1.7%

Value $2.883M (-82.9%) Shares 538,841 (-81.0%) Est. Cost $3.56 Unrealized —

NXTC NEXTCURE INC 0.0%

Value $72,967 (-95.2%) Shares 44,347 (-71.1%) Est. Cost $5.23 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ORIC	ORIC PHARMACEUTICALS INC	372,904 (-92.2%)	$3.554M (-93.8%)	2.1%	$9.18	—	COM	68622P109
ZURA	ZURA BIO LTD	538,841 (-81.0%)	$2.883M (-82.9%)	1.7%	$3.56	—	CLASS A ORD SHS	G9TY5A101
NXTC	NEXTCURE INC	44,347 (-71.1%)	$72,967 (-95.2%)	0.0%	$5.23	—	COM NEW	65343E207

Unchanged Positions (14)

PYXS PYXIS ONCOLOGY INC 11.4%

Value $19.48M Shares 7,032,770 Est. Cost $2.88 Unrealized —

ARVN ARVINAS INC 16.2%

Value $27.66M Shares 3,457,815 Est. Cost $24.30 Unrealized —

BHVN BIOHAVEN LTD 4.7%

Value $8.004M Shares 505,645 Est. Cost $46.66 Unrealized —

ALLO ALLOGENE THERAPEUTICS INC 27.5%

Value $46.93M Shares 22,032,040 Est. Cost $2.47 Unrealized —

ZNTL ZENTALIS PHARMACEUTICALS INC 2.3%

Value $3.853M Shares 953,834 Est. Cost $3.28 Unrealized —

CELC CELCUITY INC 17.3%

Value $29.55M Shares 295,652 Est. Cost $14.11 Unrealized —

WVE WAVE LIFE SCIENCES LTD 6.4%

Value $10.93M Shares 1,875,000 Est. Cost $13.35 Unrealized —

CRDF CARDIFF ONCOLOGY INC 1.8%

Value $3.014M Shares 2,411,575 Est. Cost $3.13 Unrealized —

CRBU CARIBOU BIOSCIENCES INC 4.6%

Value $7.88M Shares 4,690,431 Est. Cost $2.01 Unrealized —

AGMB AGOMAB THERAPEUTICS NV 0.6%

Value $1.036M Shares 75,000 Est. Cost $10.85 Unrealized —

SPRO SPERO THERAPEUTICS INC 3.1%

Value $5.339M Shares 2,362,348 Est. Cost $1.19 Unrealized —

DNA GINKGO BIOWORKS HOLDINGS INC 0.0%

Value $30,012 Shares 2,928 Est. Cost $8.57 Unrealized —

BOLT BOLT BIOTHERAPEUTICS INC 0.1%

Value $134K Shares 31,305 Est. Cost $6.62 Unrealized —

— SENSEONICS HLDGS INC 0.0%

Value $12,418 Shares 2,171 Est. Cost $0.52 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PYXS	PYXIS ONCOLOGY INC	7,032,770	$19.48M	11.4%	$2.88	—	COMMON STOCK	747324101
ARVN	ARVINAS INC	3,457,815	$27.66M	16.2%	$24.30	—	COM	04335A105
BHVN	BIOHAVEN LTD	505,645	$8.004M	4.7%	$46.66	—	COM	G1110E107
ALLO	ALLOGENE THERAPEUTICS INC	22,032,040	$46.93M	27.5%	$2.47	—	COM	019770106
ZNTL	ZENTALIS PHARMACEUTICALS INC	953,834	$3.853M	2.3%	$3.28	—	COM	98943L107
CELC	CELCUITY INC	295,652	$29.55M	17.3%	$14.11	—	COM	15102K100
WVE	WAVE LIFE SCIENCES LTD	1,875,000	$10.93M	6.4%	$13.35	—	SHS	Y95308105
CRDF	CARDIFF ONCOLOGY INC	2,411,575	$3.014M	1.8%	$3.13	—	COM	14147L108
CRBU	CARIBOU BIOSCIENCES INC	4,690,431	$7.88M	4.6%	$2.01	—	COM	142038108
AGMB	AGOMAB THERAPEUTICS NV	75,000	$1.036M	0.6%	$10.85	—	ADS	00860C102
SPRO	SPERO THERAPEUTICS INC	2,362,348	$5.339M	3.1%	$1.19	—	COM	84833T103
DNA	GINKGO BIOWORKS HOLDINGS INC	2,928	$30,012	0.0%	$8.57	—	CL A NEW	37611X209
BOLT	BOLT BIOTHERAPEUTICS INC	31,305	$134K	0.1%	$6.62	—	COM NEW	097702203
—	SENSEONICS HLDGS INC	2,171	$12,418	0.0%	$0.52	—	COM	81727U105